Provider CornerFEATURING: July 13, 2023Cleveland Clinic Performs World’s First Implant of Combined Heart Failure TherapiesCleveland Clinic has successfully implanted a dual cardiac device in the first patient in the world as part of a clinical trial, which aims to potentially treat heart failure symptoms. The INTEGRA-D clinical study will evaluate the safety and effectiveness of a device that combines two …
Heart Transplant Innovation: New ‘heart in a box’ technology provides gift of life to Arizona man, as couple prepares to celebrate 50-year anniversary
Provider CornerFEATURING: June 15, 2023Heart Transplant Innovation: New ‘heart in a box’ technology provides gift of life to Arizona man, as couple prepares to celebrate 50-year anniversary Breakthrough technology known as “heart in a box” is giving hope to thousands of people in need of heart transplants. Traditionally, donor hearts were retrieved from patients who were declared brain dead, but their …
The future of Wilms tumor therapies: Q&A with Jeffrey Dome, M.D., Ph.D.
Provider CornerFEATURING:May 18, 2023The future of Wilms tumor therapies: Q&A with Jeffrey Dome, M.D., Ph.D. Conducting Wilms tumor research has placed Children’s National Hospital as the leader in this space. Jeffrey Dome, M.D., Ph.D., talks about the future of Wilms tumor therapies and what excites him about being able to offer different treatment options to this group of patients. Q: What’s next for …
In a first, Mayo Clinic treats cardiologypatient with phage therapy
Provider CornerFEATURING: April 13, 2023In a first, Mayo Clinic treats cardiologypatient with phage therapyMark Ulland, a Mayo Clinic patient, recently received a lifesaving combination of phage therapy followed by a heart transplant. It is the first time Mayo Clinic has ever used phages to treat a cardiology patient. It is also the first time in years that Mark has felt hopeful. “I’m …
Using high-intensity focused ultrasound to treat solid tumors
Provider CornerFEATURING:March 16, 2023Using high-intensity focused ultrasound to treat solid tumors“I think high-intensity focused ultrasound is a really exciting technology that will allow for a different paradigm of how we think about treating solid tumors, both in a local and in a systemic way,” says AeRang Kim, M.D., oncologist at Children’s National Hospital. Dr. Kim explains high-intensity focused ultrasound (HIFU) and …
Cutting-edge lab work at Mayo Clinic cracks a medical mystery
Provider CornerFEATURING:February 19, 2023Cutting-edge lab work at Mayo Clinic cracks a medical mystery A deep dive into Kenneth Hobby’s DNA yielded a correct diagnosis and relief from disabling pain. Kenneth Hobby assumed his fever, fatigue, and aching pains in May 2018 were from another bout of malaria. He was on one of his frequent visits to Zambia in southern Africa, …
Brain tumor team performs first ever LIFU procedure on pediatric DIPG patient
Provider CornerFEATURING:January 19, 2023Brain tumor team performs first ever LIFU procedure on pediatric DIPG patientA multidisciplinary brain tumor team at Children’s National Hospital successfully performed the first treatment with sonodynamic therapy utilizing low intensity focused ultrasound (LIFU) and 5-aminolevulinic acid (5-ALA) medication on a pediatric patient. The treatment, performed on a 5-year-old child diagnosed with a diffuse intrinsic pontine glioma (DIPG), …
Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors
Provider CornerFEATURING:January 5, 2023Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors We sat down with Dr. Michael Vogelbaum, Program Leader of Neuro-Oncology and Chief of Neurosurgery, to discuss stereotactic radiosurgery for brain tumors. What is stereotactic surgery and how is it different from radiation therapy? Stereotactic radiosurgery is a non-invasive treatment that is delivered with the highest precision, …
Spotlight: Center for BRCA and Related Genes
Inherited mutations in BRCA1, BRCA2, and other BRCA-related DNA repair genes confer increased risk of multiple tumor types – particularly breast, ovarian, pancreatic, and prostate cancers. Moreover, it is now clear that many cancers can acquire mutations in the BRCA and other related DNA repair genes only in their tumor cells, even though the patient was not born with the genetic mutation.
Qatar Rehabilitation Institute Launches Partnership With Leading U.S. Rehabilitation Hospital
Atrium Health’s Carolinas Rehabilitation (CR), of Charlotte, North Carolina, ratified a new partnership with the Qatar rehabilitation Institute (QRI) in Doha earlier this year. QRI is the region’s largest tertiary rehabilitation hospital and is part of the Hamad Medical Corp. (HMC), the principal public healthcare provider in Qatar.